Savage Edward B, Grab Joshua D, O'Brien Sean M, Ali Aman, Okum Eric J, Perez-Tamayo R Anthony, Eiferman Daniel S, Peterson Eric D, Edwards Fred H, Higgins Robert S D
Department of Surgery, St. John's Mercy Medical Center, St. Louis, Missouri, USA.
Ann Thorac Surg. 2007 Mar;83(3):1002-6. doi: 10.1016/j.athoracsur.2006.09.094.
Use of both internal thoracic arteries has been limited in diabetic patients fearing an increased incidence of deep sternal wound infection. We analyzed this concern by querying The Society of Thoracic Surgeons Database.
Diabetic patients who had isolated coronary artery bypass graft surgery during 2002 to 2004 were included if they had no prior bypass surgery, two or more distal bypasses, and a left internal thoracic artery bypass. Group B (both internal thoracic arteries) was compared with group L (left internal thoracic artery only).
The incidence of deep sternal wound infection for all patients undergoing isolated first-time bypass surgery was less than 1%. Of these, 120,793 patients met criteria for inclusion: group B, 1.4% (1732); and group L, 98.6% (119,061). Group B had a higher crude (unadjusted) deep sternal wound infection rate of 2.8% (49) versus 1.7% (1969; p = 0.0005) in group L, with an estimated odds ratio of 2.23 (95% confidence interval, 1.69 to 2.96). Group B had a similar crude mortality rate of 1.7% (30) versus 2.3% (2785; p = NS) in group L, with an estimated odds ratio of 1.110 (95% CI, 0.78 to 1.59; p = NS). Patients in group B were younger, mostly male, had a lower serum creatinine level, and were more often current smokers; less commonly, they were insulin dependent, diagnosed with pulmonary or vascular disease, or on dialysis. Other risk factors for deep sternal would infection included female gender, insulin dependence, peripheral vascular disease, recent infarction, body mass index exceeding 35 kg/m2, and use of blood products.
There is a significant increase in the incidence of deep sternal would infection in diabetic patients. This is further increased with the use of both internal thoracic arteries with no apparent short-term mortality difference.
由于担心深部胸骨伤口感染发生率增加,双侧胸廓内动脉的使用在糖尿病患者中受到限制。我们通过查询胸外科医师协会数据库来分析这一问题。
纳入2002年至2004年期间接受单纯冠状动脉旁路移植手术的糖尿病患者,这些患者既往无旁路手术史、有两个或更多远端旁路且有左胸廓内动脉旁路。将B组(双侧胸廓内动脉)与L组(仅左胸廓内动脉)进行比较。
所有接受单纯首次旁路手术的患者深部胸骨伤口感染发生率低于1%。其中,120793例患者符合纳入标准:B组,1.4%(1732例);L组,98.6%(119061例)。B组的粗(未调整)深部胸骨伤口感染率较高,为2.8%(49例),而L组为1.7%(1969例;p = 0.0005),估计优势比为2.23(95%置信区间,1.69至2.96)。B组的粗死亡率相似,为1.7%(30例),而L组为2.3%(2785例;p = 无显著性差异),估计优势比为1.110(95% CI,0.78至1.59;p = 无显著性差异)。B组患者更年轻,多为男性,血清肌酐水平较低,且当前吸烟者更多;较少见的是,他们依赖胰岛素、被诊断患有肺部或血管疾病或正在接受透析。深部胸骨伤口感染的其他危险因素包括女性、胰岛素依赖、外周血管疾病、近期梗死、体重指数超过35 kg/m²以及使用血制品。
糖尿病患者深部胸骨伤口感染发生率显著增加。使用双侧胸廓内动脉会使这一情况进一步增加,且无明显短期死亡率差异。